Characterization of [(3)H]harmane binding to rat whole brain membranes. 2003

N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK.

This study investigates the binding of [(3)H]harmane to rat whole brain homogenates. Saturation studies revealed [(3)H]harmane labels a single, saturable, high-capacity population with high affinity. All the test compounds displaced [(3)H]harmane completely and in an apparently monophasic manner. The displacement profile of the test ligands indicated labeling of MAO-A. Given the high level of MAO-A binding, it is unlikely that a low-capacity I(2) site would be distinguishable from the total [(3)H]harmane population.

UI MeSH Term Description Entries
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006247 Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's. 9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-,Banisterine,Leucoharmine,Telepathine,Yageine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D014316 Tritium The radioactive isotope of hydrogen also known as hydrogen-3. It contains two NEUTRONS and one PROTON in its nucleus and decays to produce low energy BETA PARTICLES. Hydrogen-3,Hydrogen 3
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
April 2004, Neurochemical research,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
February 2002, British journal of pharmacology,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
January 1990, Neurochemistry international,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
January 1987, Neurochemistry international,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
March 1995, British journal of pharmacology,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
November 1984, Neuroscience letters,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
March 1993, General pharmacology,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
January 1988, Neurochemistry international,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
January 1985, Neurochemistry international,
N J Anderson, and E S J Robinson, and S M Husbands, and P Delagrange, and D J Nutt, and A L Hudson
January 1972, Naunyn-Schmiedeberg's archives of pharmacology,
Copied contents to your clipboard!